Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurocritical Care
Published in: Neurocritical Care 2/2017

01-10-2017 | Original Article

Procalcitonin is a Poor Predictor of Non-Infectious Fever in the Neurocritical Care Unit

Authors: Karin Halvorson, Sameer Shah, Corey Fehnel, Bradford Thompson, N. Stevenson Potter, Mitchell Levy, Linda Wendell

Published in: Neurocritical Care | Issue 2/2017

Login to get access

Abstract

Background

Fever is a common occurrence in the Neurocritical Care Unit (NCCU). It is reported that up to 50 % of these fevers are associated with a non-infectious source. As this is a diagnosis of exclusion, a complete fever evaluation must be done to rule out infection. Procalcitonin (PCT) has been identified as a possible biomarker to distinguish infectious from non-infectious etiologies of fever. We hypothesized that PCT could be used as a predictor of infectious fever in febrile patients with intracranial hemorrhage admitted to the NCCU.

Methods

A prospective observational cohort of patients admitted to a 12-bed NCCU in a tertiary-care university hospital from January 1, 2014, to October 1, 2014, was studied. Patients with intracranial hemorrhage (aneurismal subarachnoid hemorrhage, traumatic brain injury, intracerebral hemorrhage, or non-traumatic subdural hemorrhage) and fever defined as ≥101.4 °F were included. All patients had a urinalysis, chest X-ray, two sets of blood cultures, and PCT as part of their fever evaluation. Patients also had urine, sputum, CSF cultures, and Clostridium difficile toxin PCR as clinically indicated. Patients with incomplete fever evaluations were excluded.

Results

Seventy-three patients met inclusion criteria: 36 had infections identified and 37 did not. Type of intracranial hemorrhage was similar between groups. For those with identified infection, median PCT was 0.15 ng/mL (IQR 0.06–0.5 ng/mL). For those without identified infection, median PCT was 0.09 ng/mL (IQR 0.05–0.45 ng/mL), p = 0.30. Analyzing subgroups of intracranial hemorrhage patients revealed no group with a significant difference in PCT values. Patients with identified infection did have higher white blood cell counts (median 14.1 × 109/L (11.6–17.4 × 109/L) compared to those without identified infection 12 × 109/L (9.9–14.1 × 109/L), p = 0.02.

Conclusion

Among patients with intracranial hemorrhage, PCT did not differentiate infectious fever from non-infectious fever.
Literature
1.
Rabinstein AA, Sandhu K. Non-infectious fever in the neurological intensive care unit: incidence, causes and predictors. J Neurol Neurosurg Psychiatry. 2007;78(11):1278–80.CrossRefPubMedPubMedCentral
2.
Commichau C, Scarmeas N, Mayer SA. Risk factors for fever in the neurologic intensive care unit. Neurology. 2003;60(5):837–41.CrossRefPubMed
3.
Thompson HJ, Pinto-Martin J, Bullock MR. Neurogenic fever after traumatic brain injury: an epidemiological study. J Neurol Neurosurg Psychiatry. 2003;74(5):614–9.CrossRefPubMedPubMedCentral
4.
5.
Buratti T, et al. Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction. Inflammation. 2001;25(2):97–100.CrossRefPubMed
6.
Castelli GP, et al. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004;8(4):R234–42.CrossRefPubMedPubMedCentral
7.
Harbarth S, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164(3):396–402.CrossRefPubMed
8.
Matzaraki V, et al. Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis. Clin Biochem. 2007;40(5–6):336–42.CrossRefPubMed
9.
Al-Nawas B, Krammer I, Shah PM. Procalcitonin in diagnosis of severe infections. Eur J Med Res. 1996;1(7):331–3.PubMed
10.
Mann EA, Wood GL, Wade CE. Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. Burns. 2011;37(4):549–58.CrossRefPubMed
11.
Muller B, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000;28(4):977–83.CrossRefPubMed
12.
Wanner GA, et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med. 2000;28(4):950–7.CrossRefPubMed
13.
Rudy T, Pathogenesis of fever associated with cerebral trauma and intracranial hemorrhage. In: Cox B editor. Thermoregulatory mechanisms and therapeutic implications, Vol. 4th. International Symposium on the Pharmacology of Thermoregulation. Switzerland; 1980.
14.
Dietrich WD, et al. Delayed posttraumatic brain hyperthermia worsens outcome after fluid percussion brain injury: a light and electron microscopic study in rats. Neurosurgery. 1996;38(3):533–41 discussion 541.PubMed
15.
Suprin E, et al. Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med. 2000;26(9):1232–8.CrossRefPubMed
16.
Ugarte H, et al. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med. 1999;27(3):498–504.CrossRefPubMed
17.
Kumar A, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–96.CrossRefPubMed
18.
Ferrer R, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749–55.CrossRefPubMed
19.
Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother. 2011;66(Suppl 2):33–40.
20.
Schuetz P, et al. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care. 2013;17(3):R115.CrossRefPubMedPubMedCentral
21.
Friend KE, et al. Procalcitonin elevation suggests a septic source. Am Surg. 2014;80(9):906–9.PubMed
22.
Liu HH, et al. Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria. Ir J Med Sci. 2016. doi:10.​1007/​s11845-016-1457-z.
23.
24.
Festic E, et al. The utility of serum procalcitonin in distinguishing systemic inflammatory response syndrome from infection after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2014;20(3):375–81.CrossRefPubMed
Metadata
Title
Procalcitonin is a Poor Predictor of Non-Infectious Fever in the Neurocritical Care Unit
Authors
Karin Halvorson
Sameer Shah
Corey Fehnel
Bradford Thompson
N. Stevenson Potter
Mitchell Levy
Linda Wendell
Publication date
01-10-2017
Publisher
Springer US
Published in
Neurocritical Care / Issue 2/2017
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-016-0337-8

Other articles of this Issue 2/2017

Neurocritical Care 2/2017 Go to the issue

Ethical Matters

Palliative Care Needs Assessment in the Neuro-ICU: Effect on Family

Neuroimage

Coxsackie B3/B4-Related Acute Flaccid Myelitis

Editorial

Caring for Patients’ Families (or Lack of Family) in Neurocritical Care

Review Article

Nutritional and Bioenergetic Considerations in Critically Ill Patients with Acute Neurological Injury

Original Article

Early-Onset Ventilator-Associated Pneumonia in Patients with Severe Traumatic Brain Injury: Incidence, Risk Factors, and Consequences in Cerebral Oxygenation and Outcome

Translational Research

Effects of Mild Hypothermia on Cerebral Large and Small Microvessels Blood Flow in a Porcine Model of Cardiac Arrest